According to two international studies presented at the ESMO Congress 2024 in Barcelona, women who breastfeed after...
mutation
A new study found that most survivors of stage 0 through stage III breast cancer who try...
Grant of up to $11 million will fund a clinical trial at UCSF that uses a smarter...
Daiichi Sankyo Company, Limited announced comprehensive analyses of overall survival from the pivotal QuANTUM-R phase 3 study...
Zepsyre® (lurbinectedin), from PharmaMar (MSE:PHM), showed noteworthy clinical activity in patients with metastatic breast cancer that have...
Two-year maintenance therapy with olaparib, a PARP (poly ADP ribose polymerase) inhibitor, olaparib, led to a substantial,...
Over half of newly diagnosed advanced or metastatic basal cell carcinomas are resistant to currently approved drug...
Thanks to DNA sequencing, patients with rare cancers for which no standard treatment is available could receive...
In a study of an immune therapy for colorectal cancer that involved a single patient, a team...
E-cigarette vapour does not induce DNA mutations commonly observed with tobacco smoke exposures in lab-based tests.